glp 1 and eating disorders GLP-1 Medications Disorders: Risks, Benefits & Mental Health Support Eating Disorders | Wise Mind

The potential advent of an effective tau-directed disease-targeted therapies (DTTs) for AD may increase the volume of patients presenting earlier in the disease continuum, and increase complexity in workflow, infrastructure, treatment decision-making, treatment administration and monitoring, and patient tracking

As-needed administration is recommended only for those experienced with Calocurb CLINICAL and knowledgeable of their individual response

[Crossref] [PubMed] Aronne LJ, Sattar N, Horn DB, et al

While GLP-1s are effective for weight loss, they are not clinically appropriate for everyone

Fatigue and Dizziness General weakness, dizziness, and loss of energy are frequently reported, particularly during early dose titration

Without that clinical context, its easy for associations to be made that arent necessarily causal